ANGIOGUARD® RX Emboli Capture Guidewire System

The Cordis ANGIOGUARD® RX Guidewire System is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures.*

ANGIOGUARD® RX Guidewire System offers:

  • One of the shortest landing Zones: Short filter basket enables ability to center in tortuous anatomy.
  • Stroke Reduction: Polyurethane membrane with 100 pores captures clinically relevant emboli and shown in clinical testing to reduce the rate of stroke.
  • Self-Centering: The unique umbrella design centers in the vessel with high device delivery success and excellent wall apposition.
  • Visibility: Eight Nitinol struts keep the symmetric basket in contact with the arterial wall, with marker bands on every other strut, in addition to a proximal and distal marker band to ensure high visibility during the procedure.
  • Excellent Crossability: Profile as low as 3.2F facilitates crossing difficult lesions.

 

For indications, contraindications, warnings, precautions, and adverse events, please read the Essential Prescribing Information (EPI).

Learn more about our full line of Endovascular products: Download the complete Endovascular product catalog PDF.

To place an order for a Cordis product please visit the
JOHNSON & JOHNSON GATEWAY® Commerce Web site at http://www.commerce.jnjgateway.com.

*30-day pooled data from U. S. feasibility study and European CASCADE Study